搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus ducreyi DNA ligase (ligA), partial CSB-YP756382HSY
CSB-EP756382HSY
CSB-BP756382HSY
CSB-MP756382HSY
CSB-EP756382HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Membrane-bound lytic murein transglycosylase F (mltF) CSB-YP756383HSY
CSB-EP756383HSY
CSB-BP756383HSY
CSB-MP756383HSY
CSB-EP756383HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Triosephosphate isomerase (tpiA) CSB-YP756384HSY
CSB-EP756384HSY
CSB-BP756384HSY
CSB-MP756384HSY
CSB-EP756384HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Nucleoid occlusion factor SlmA (slmA) CSB-YP756385HSY
CSB-EP756385HSY
CSB-BP756385HSY
CSB-MP756385HSY
CSB-EP756385HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Sec-independent protein translocase protein TatB (tatB), partial CSB-YP756386HSY
CSB-EP756386HSY
CSB-BP756386HSY
CSB-MP756386HSY
CSB-EP756386HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Protein-export protein SecB (secB) CSB-YP756387HSY
CSB-EP756387HSY
CSB-BP756387HSY
CSB-MP756387HSY
CSB-EP756387HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Aspartate--tRNA ligase (aspS), partial CSB-YP756388HSY
CSB-EP756388HSY
CSB-BP756388HSY
CSB-MP756388HSY
CSB-EP756388HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi 7-cyano-7-deazaguanine synthase (queC) CSB-YP756389HSY
CSB-EP756389HSY
CSB-BP756389HSY
CSB-MP756389HSY
CSB-EP756389HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Putative 23S rRNA (uracil (747)-C (5))-methyltransferase RlmC (rlmC) CSB-YP756390HSY
CSB-EP756390HSY
CSB-BP756390HSY
CSB-MP756390HSY
CSB-EP756390HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Glucose-6-phosphate isomerase (pgi), partial CSB-YP756391HSY
CSB-EP756391HSY
CSB-BP756391HSY
CSB-MP756391HSY
CSB-EP756391HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Electron transport complex protein RnfC (rnfC), partial CSB-YP756392HSY
CSB-EP756392HSY
CSB-BP756392HSY
CSB-MP756392HSY
CSB-EP756392HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Na (+)-translocating NADH-quinone reductase subunit B (nqrB), partial CSB-YP756393HSY
CSB-EP756393HSY
CSB-BP756393HSY
CSB-MP756393HSY
CSB-EP756393HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Protease HtpX (htpX), partial CSB-YP756394HSY1
CSB-EP756394HSY1
CSB-BP756394HSY1
CSB-MP756394HSY1
CSB-EP756394HSY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Thiosulfate sulfurtransferase glpE (glpE) CSB-YP756395HSY
CSB-EP756395HSY
CSB-BP756395HSY
CSB-MP756395HSY
CSB-EP756395HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB (rlmB) CSB-YP756396HSY
CSB-EP756396HSY
CSB-BP756396HSY
CSB-MP756396HSY
CSB-EP756396HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP756397HSY
CSB-EP756397HSY
CSB-BP756397HSY
CSB-MP756397HSY
CSB-EP756397HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Thiamine import ATP-binding protein ThiQ (thiQ) CSB-YP756398HSY
CSB-EP756398HSY
CSB-BP756398HSY
CSB-MP756398HSY
CSB-EP756398HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi 50S ribosomal protein L27 (rpmA) CSB-YP756399HSY
CSB-EP756399HSY
CSB-BP756399HSY
CSB-MP756399HSY
CSB-EP756399HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi RNA pyrophosphohydrolase (rppH) CSB-YP756400HSY
CSB-EP756400HSY
CSB-BP756400HSY
CSB-MP756400HSY
CSB-EP756400HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Periplasmic nitrate reductase (napA), partial CSB-YP756401HSY
CSB-EP756401HSY
CSB-BP756401HSY
CSB-MP756401HSY
CSB-EP756401HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>